Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Peringkat dalam Saham #16436
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Harga Saham
$4.64
Terakhir disinkronkan: 2022-09-12
Kapitalisasi Pasar
$293.43M
Perubahan (1 hari)
0.87%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Adagio Therapeutics, Inc. (ADGI)

Kategori

Riwayat harga saham Adagio Therapeutics, Inc. (ADGI)
Harga penutupan tertinggi: $4.63 pada 2022-09-01

Harga penutupan terendah: $27.68 pada 2021-08-01
Riwayat harga saham Adagio Therapeutics, Inc. dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2022 -78.16%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.14 -10.08%
AU
$748.60 6.90%
CH